Cargando…

Idiopathic pulmonary fibrosis: A guide for nurse practitioners

Idiopathic pulmonary fibrosis (IPF) is a rare disease characterized by decline in lung function, dyspnea, and cough. The clinical course of IPF is variable and unpredictable. Early referral to specialists is key to ensure timely and accurate diagnosis. Two antifibrotic drugs (nintedanib and pirfenid...

Descripción completa

Detalles Bibliográficos
Autores principales: Vega-Olivo, Michelle, Criner, Gerard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springhouse Corp 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916481/
https://www.ncbi.nlm.nih.gov/pubmed/29465476
http://dx.doi.org/10.1097/01.NPR.0000531121.07294.36
_version_ 1783317018777223168
author Vega-Olivo, Michelle
Criner, Gerard J.
author_facet Vega-Olivo, Michelle
Criner, Gerard J.
author_sort Vega-Olivo, Michelle
collection PubMed
description Idiopathic pulmonary fibrosis (IPF) is a rare disease characterized by decline in lung function, dyspnea, and cough. The clinical course of IPF is variable and unpredictable. Early referral to specialists is key to ensure timely and accurate diagnosis. Two antifibrotic drugs (nintedanib and pirfenidone) have been approved for the treatment of IPF.
format Online
Article
Text
id pubmed-5916481
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springhouse Corp
record_format MEDLINE/PubMed
spelling pubmed-59164812018-05-02 Idiopathic pulmonary fibrosis: A guide for nurse practitioners Vega-Olivo, Michelle Criner, Gerard J. Nurse Pract Feature: LUNG DISEASE Idiopathic pulmonary fibrosis (IPF) is a rare disease characterized by decline in lung function, dyspnea, and cough. The clinical course of IPF is variable and unpredictable. Early referral to specialists is key to ensure timely and accurate diagnosis. Two antifibrotic drugs (nintedanib and pirfenidone) have been approved for the treatment of IPF. Springhouse Corp 2018-05-17 2018-02-21 /pmc/articles/PMC5916481/ /pubmed/29465476 http://dx.doi.org/10.1097/01.NPR.0000531121.07294.36 Text en Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Feature: LUNG DISEASE
Vega-Olivo, Michelle
Criner, Gerard J.
Idiopathic pulmonary fibrosis: A guide for nurse practitioners
title Idiopathic pulmonary fibrosis: A guide for nurse practitioners
title_full Idiopathic pulmonary fibrosis: A guide for nurse practitioners
title_fullStr Idiopathic pulmonary fibrosis: A guide for nurse practitioners
title_full_unstemmed Idiopathic pulmonary fibrosis: A guide for nurse practitioners
title_short Idiopathic pulmonary fibrosis: A guide for nurse practitioners
title_sort idiopathic pulmonary fibrosis: a guide for nurse practitioners
topic Feature: LUNG DISEASE
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916481/
https://www.ncbi.nlm.nih.gov/pubmed/29465476
http://dx.doi.org/10.1097/01.NPR.0000531121.07294.36
work_keys_str_mv AT vegaolivomichelle idiopathicpulmonaryfibrosisaguidefornursepractitioners
AT crinergerardj idiopathicpulmonaryfibrosisaguidefornursepractitioners